Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis

Journal of Surgical Research

Volumn 76, Issue 1, 1998, Pages 67-73

  Wang, Stewart C ^a   Klein, Richard D ^a   Wahl, Wendy L ^a   Alarcon, William H ^a   Garg, Ravin J ^a   Remick, Daniel G ^a   Su, Grace L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CD14; Critical care; Lipopolysaccharide binding protein (LBP); MRNA; Sepsis; Shock; Trauma

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; IMIPENEM; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL PERITONITIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; INJURY; INTENSIVE CARE; KIDNEY; LAPAROTOMY; LIVER; LUNG; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SURGICAL PATIENT;

EID: 0031902111     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5290     Document Type: Conference Paper

References (35)

1. Luster M. I., Germolec D. R., Yoshida T., Kayama F., Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology. 19:1994;480-488.
2. Bautista A. P., Spitzer J. J., Luster M. I. Acute endotoxin tolerance downregulates superoxide anion release by the perfused liver and isolated hepatic nonparenchymal cells. Hepatology. 21:1995;855-862.
3. Arthur M. J., Kowalski-Saunders P., Wright R. Effect of endotoxin on release of reactive oxygen intermediates by rat hepatic macrophages. Gastroenterology. 95:1988;1588-1594.
4. Tracey K. J., Fong Y., Hesse D. G. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
5. Hartung T., Wendel A. Endotoxin-inducible cytotoxicity in liver cell cultures - I. Biochem. Pharmacol. 42:1991;1129-1135.
6. Hishinuma I., Nagakawa J., Hirota K. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology. 12:1990;1187-1191.
7. Nanji A. A., Zhao S., Sadrzadeh S. M. Use of reverse transcription-polymerase chain reaction to evaluatein vivo. Hepatology. 19:1994;1483-1487.
8. Hasday J. D., Dubin W., Mongovin S. Bronchoalveolar macrophage CD14 expression: Shift between membrane-associated and soluble pools. Am. J. Physiol. 272:1997;L925-L933.
9. Troelstra A., Giepmans B. N., Van Kessel K. P., Lichenstein H. S., Verhoef J., Van Strijp J. A. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukocyte Biol. 61:1997;173-178.
10. Feder L. S., Todaro J. A., Laskin D. L. Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J. Leukocyte Biol. 53:1993;126-132.
11. Thiele D. L. Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease. Hepatology. 9:1989;497-499.
12. Hansen J., Cherwitz D. L., Allen J. I. The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology. 20:1994;461-474.
13. Felver M. E., Mezey E., McGuire M. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin. Exp. Res. 14:1990;255-259.
14. Bhagwandeen B. S., Apte M., Manwarring L., Dickeson J. Endotoxin induced hepatic necrosis in rats on an alcohol diet. J. Pathol. 151:1987;47-53.
15. Tsukamoto H., Towner S. J., Ciofalo L. M., French S. W. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology. 6:1986;814-822.
16. Nanji A. A., Griniuviene B., Yacoub L. K., Fogt F., Tahan S. R. Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: Relationship to endotoxemia and TNF alpha messenger RNA. Exp. Mol. Pathol. 62:1995;42-51.
17. Nanji A. A., Khettry U., Sadrzadeh S. M., Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. J. Pathol. 142:1993;367-373.
18. Adachi Y., Bradford B. U., Gao W., Bojes H. K., Thurman R. G. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology. 20:1994;453-460.
19. Nanji A. A., Khettry U., Sadrzadeh S. M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205:1994;243-247.
20. Adachi Y., Moore L. E., Bradford B. U., Gao W., Thurman R. G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 108:1995;218-224.
21. Nolan J. P., Camara D. S. Intestinal endotoxins as co-factors in liver injury [Review]. Immunol. Invest. 18:1989;325-337.
22. Camara D. S., Caruana J. A. Jr., Schwartz K. A., Montes M., Nolan J. P. D-Galactosamine liver injury: Absorption of endotoxin and protective effect of small bowel and colon resection in rabbits. Proc. Soc. Exp. Biol. Med. 172:1983;255-259.
23. Czaja M. J., Xu J., Ju Y., Alt E., Schmiedeberg P. Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration. Hepatology. 19:1994;1282-1289.
24. Nakao A., Taki S., Yasui M. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology. 19:1994;1251-1256.
25. Lin R. S., Lee F. Y., Lee S. D. Endotoxemia in patients with chronic liver diseases: Relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J. Hepatol. 22:1995;165-172.
26. Bigatello L. M., Broitman S. A., Fattori L. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 82:1987;11-15.
27. Mathison J. C., Ulevitch R. J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J. Immunol. 123:1979;2133-2143.
28. Mimura Y., Sakisaka S., Harada M., Sata M., Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology. 109:1995;1969-1976.
29. Maitra S. K., Rachmilewitz D., Eberle D., Kaplowitz N. The hepatocellular uptake and biliary excretion of endotoxin in the rat. Hepatology. 1:1981;401-407.
30. Schumann R. R., Rietschel E. T., Loppnow H. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin [Review]. Med. Microbiol. Immunol. 183:1994;279-297.
31. Fox E. S., Broitman S. A., Thomas P. Bacterial endotoxins and the liver [Review]. Lab. Invest. 63:1995;733-741.
32. Tobias P. S., Soldau K., Ulevitch R. J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264:1989;10867-10871.
33. Freudenberg M. A., Freudenberg N., Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. J. Exp. Pathol. 63:1982;56-65.
34. Ruiter D. J., van der Meulen J., Brouwer A. Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 45:1981;38-45.
35. Treon S. P., Thomas P., Broitman S. A. Lipopolysaccharide (LPS) processing by Kupffer cells releases a modified LPS with increased hepatocyte binding and decreased tumor necrosis factor-alpha stimulatory capacity. Proc. Soc. Exp. Biol. Med. 202:1993;153-158.